ReviewMolecules (Basel, Switzerland)2016

Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis.

Souvik Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.